293 related articles for article (PubMed ID: 9880544)
1. Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex.
Vassilev A; Ozer Z; Navara C; Mahajan S; Uckun FM
J Biol Chem; 1999 Jan; 274(3):1646-56. PubMed ID: 9880544
[TBL] [Abstract][Full Text] [Related]
2. BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells.
Uckun FM; Waddick KG; Mahajan S; Jun X; Takata M; Bolen J; Kurosaki T
Science; 1996 Aug; 273(5278):1096-100. PubMed ID: 8688094
[TBL] [Abstract][Full Text] [Related]
3. Bruton's tyrosine kinase is essential for hydrogen peroxide-induced calcium signaling.
Qin S; Chock PB
Biochemistry; 2001 Jul; 40(27):8085-91. PubMed ID: 11434777
[TBL] [Abstract][Full Text] [Related]
4. Rational design and synthesis of a novel anti-leukemic agent targeting Bruton's tyrosine kinase (BTK), LFM-A13 [alpha-cyano-beta-hydroxy-beta-methyl-N-(2, 5-dibromophenyl)propenamide].
Mahajan S; Ghosh S; Sudbeck EA; Zheng Y; Downs S; Hupke M; Uckun FM
J Biol Chem; 1999 Apr; 274(14):9587-99. PubMed ID: 10092645
[TBL] [Abstract][Full Text] [Related]
5. Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein.
Yamadori T; Baba Y; Matsushita M; Hashimoto S; Kurosaki M; Kurosaki T; Kishimoto T; Tsukada S
Proc Natl Acad Sci U S A; 1999 May; 96(11):6341-6. PubMed ID: 10339589
[TBL] [Abstract][Full Text] [Related]
6. Bruton's tyrosine kinase prevents activation of the anti-apoptotic transcription factor STAT3 and promotes apoptosis in neoplastic B-cells and B-cell precursors exposed to oxidative stress.
Uckun F; Ozer Z; Vassilev A
Br J Haematol; 2007 Feb; 136(4):574-89. PubMed ID: 17367410
[TBL] [Abstract][Full Text] [Related]
7. Bruton's tyrosine kinase (BTK) as a dual-function regulator of apoptosis.
Uckun FM
Biochem Pharmacol; 1998 Sep; 56(6):683-91. PubMed ID: 9751072
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cells.
Mahajan S; Vassilev A; Sun N; Ozer Z; Mao C; Uckun FM
J Biol Chem; 2001 Aug; 276(33):31216-28. PubMed ID: 11413148
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol 3-kinase-gamma activates Bruton's tyrosine kinase in concert with Src family kinases.
Li Z; Wahl MI; Eguinoa A; Stephens LR; Hawkins PT; Witte ON
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13820-5. PubMed ID: 9391111
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol 3-kinase-dependent membrane association of the Bruton's tyrosine kinase pleckstrin homology domain visualized in single living cells.
Várnai P; Rother KI; Balla T
J Biol Chem; 1999 Apr; 274(16):10983-9. PubMed ID: 10196179
[TBL] [Abstract][Full Text] [Related]
11. Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain.
Li T; Tsukada S; Satterthwaite A; Havlik MH; Park H; Takatsu K; Witte ON
Immunity; 1995 May; 2(5):451-60. PubMed ID: 7538439
[TBL] [Abstract][Full Text] [Related]
12. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
Buhl AM; Cambier JC
J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
[TBL] [Abstract][Full Text] [Related]
14. BCR engagement induces Fas resistance in primary B cells in the absence of functional Bruton's tyrosine kinase.
Tumang JR; Negm RS; Solt LA; Schneider TJ; Colarusso TP; Hastings WD; Woodland RT; Rothstein TL
J Immunol; 2002 Mar; 168(6):2712-9. PubMed ID: 11884437
[TBL] [Abstract][Full Text] [Related]
15. The molecular mechanism of sensitization to Fas-mediated apoptosis by 2-methoxyestradiol in PC3 prostate cancer cells.
Shimada K; Nakamura M; Ishida E; Kishi M; Matsuyoshi S; Konishi N
Mol Carcinog; 2004 Jan; 39(1):1-9. PubMed ID: 14694442
[TBL] [Abstract][Full Text] [Related]
16. A conditional form of Bruton's tyrosine kinase is sufficient to activate multiple downstream signaling pathways via PLC Gamma 2 in B cells.
Tomlinson MG; Woods DB; McMahon M; Wahl MI; Witte ON; Kurosaki T; Bolen JB; Johnston JA
BMC Immunol; 2001; 2():4. PubMed ID: 11410123
[TBL] [Abstract][Full Text] [Related]
17. Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK--functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling.
Hashimoto S; Iwamatsu A; Ishiai M; Okawa K; Yamadori T; Matsushita M; Baba Y; Kishimoto T; Kurosaki T; Tsukada S
Blood; 1999 Oct; 94(7):2357-64. PubMed ID: 10498607
[TBL] [Abstract][Full Text] [Related]
18. Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinaemia.
Hyvönen M; Saraste M
EMBO J; 1997 Jun; 16(12):3396-404. PubMed ID: 9218782
[TBL] [Abstract][Full Text] [Related]
19. Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein.
Liu W; Quinto I; Chen X; Palmieri C; Rabin RL; Schwartz OM; Nelson DL; Scala G
Nat Immunol; 2001 Oct; 2(10):939-46. PubMed ID: 11577348
[TBL] [Abstract][Full Text] [Related]
20. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2.
Takata M; Kurosaki T
J Exp Med; 1996 Jul; 184(1):31-40. PubMed ID: 8691147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
